These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1634286)

  • 21. Treatment of vitiligo with Sicorten ointment (preliminary report).
    Han GZ; Shao CG; Ye GY; Liu XQ
    Proc Chin Acad Med Sci Peking Union Med Coll; 1986; 1(1):62-3. PubMed ID: 3422996
    [No Abstract]   [Full Text] [Related]  

  • 22. Lip cosmetics.
    Engasser PG
    Dermatol Clin; 2000 Oct; 18(4):641-9, ix. PubMed ID: 11059372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous malignancies in patients treated with psoralen photochemotherapy (PUVA) for vitiligo.
    Halder RM; Battle EF; Smith EM
    Arch Dermatol; 1995 Jun; 131(6):734-5. PubMed ID: 7778934
    [No Abstract]   [Full Text] [Related]  

  • 24. Development and in vitro assessment of psoralen and resveratrol co-loaded ultradeformable liposomes for the treatment of vitiligo.
    Doppalapudi S; Mahira S; Khan W
    J Photochem Photobiol B; 2017 Sep; 174():44-57. PubMed ID: 28753523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcipotriol ointment versus clobetasol ointment in localized vitiligo: an open, comparative clinical trial.
    Köse O; Riza Gür A; Kurumlu Z; Erol E
    Int J Dermatol; 2002 Sep; 41(9):616-8. PubMed ID: 12358838
    [No Abstract]   [Full Text] [Related]  

  • 26. Topical macrolide immunomodulators: a role in the treatment of vitiligo?
    Tjioe M; Vissers WH; Gerritsen MJ
    Am J Clin Dermatol; 2006; 7(1):7-12. PubMed ID: 16489839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A rational approach to the treatment of vitiligo and other hypomelanoses.
    Hercogová J; Buggiani G; Prignano F; Lotti T
    Dermatol Clin; 2007 Jul; 25(3):383-92, ix. PubMed ID: 17662904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcipotriene and corticosteroid combination therapy for vitiligo.
    Travis LB; Silverberg NB
    Pediatr Dermatol; 2004; 21(4):495-8. PubMed ID: 15283800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.
    Parsad D; Kanwar AJ; Kumar B
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):175-7. PubMed ID: 16441626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of high-dose methylprednisolone pulse therapy in patients with progressive and stable vitiligo.
    Seiter S; Ugurel S; Tilgen W; Reinhold U
    Int J Dermatol; 2000 Aug; 39(8):624-7. PubMed ID: 10971735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of ill-defined vitiliginous lesions in the posterior polar regions of both eyes].
    Abe S; Nishikatsu H; Yasui T
    Nippon Ganka Gakkai Zasshi; 1998 Jul; 102(7):462-6. PubMed ID: 9720369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical delivery of clobetasol propionate loaded microemulsion based gel for effective treatment of vitiligo--part II: rheological characterization and in vivo assessment through dermatopharmacokinetic and pilot clinical studies.
    Patel HK; Barot BS; Parejiya PB; Shelat PK; Shukla A
    Colloids Surf B Biointerfaces; 2014 Jul; 119():145-53. PubMed ID: 24767976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Marginal vitiligo: an unusual depigmenting disorder.
    Trikha R; McCowan N; Brodell R
    Dermatol Online J; 2014 Dec; 21(3):. PubMed ID: 25780963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-psoralen treatment of vitiligo. Part II. Less commonly used and experimental therapies.
    Goldstein E; Haberman HF; Menon IA; Pawlowski D
    Int J Dermatol; 1992 May; 31(5):314-9. PubMed ID: 1587657
    [No Abstract]   [Full Text] [Related]  

  • 35. Camouflaging vitiligo using a spray tan.
    Steuer AB; Zampella JG
    Dermatol Online J; 2020 Jul; 26(7):. PubMed ID: 32898413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of vitiligo. Results of a questionnaire among dermatologists in The Netherlands.
    Njoo MD; Bossuyt PM; Westerhof W
    Int J Dermatol; 1999 Nov; 38(11):866-72. PubMed ID: 10583624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guideline for the diagnosis and management of vitiligo.
    Gawkrodger DJ; Ormerod AD; Shaw L; Mauri-Sole I; Whitton ME; Watts MJ; Anstey AV; Ingham J; Young K; ; ; ;
    Br J Dermatol; 2008 Nov; 159(5):1051-76. PubMed ID: 19036036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Why treatments do(n't) work in vitiligo: An autoinflammatory perspective.
    Speeckaert R; Speeckaert MM; van Geel N
    Autoimmun Rev; 2015 Apr; 14(4):332-40. PubMed ID: 25500433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interventions for Vitiligo.
    Ezzedine K; Whitton M; Pinart M
    JAMA; 2016 Oct; 316(16):1708-1709. PubMed ID: 27784078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral and topical L-phenylalanine, clobetasol propionate, and UVA/sunlight--a new study for the treatment of vitiligo.
    Camacho F; Mazuecos J
    J Drugs Dermatol; 2002 Sep; 1(2):127-31. PubMed ID: 12847735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.